BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 17, 2011
View Archived Issues
GlaxoSmithKline discloses first-in-human data on GSK-2126458 and GSK-2141795
Read More
Roche presents new inhibitors of the Mdm2-p53 interaction
Read More
Novel hepatocyte growth factor receptor inhibitors patented
Read More
Phase II extension trial evaluates continued E-5501 treatment of thrombocytopenia
Read More
Phase II ARQ-197 trial assesses safety and efficacy in relapsed/refractory non-CNS germ cell tumors
Read More
Pilot study supports tolerability of AC-480 in patients with recurrent malignant glioma
Read More
Receptos designs new lysophospholipid S1P1 receptor agonists
Read More
Novel chemokine CXCR4 receptor ligands patented
Read More
Zealand Pharma and Boehringer Ingelheim join to advance new drugs for type 2 diabetes and obesity
Read More
Tradjenta tablets launched in U.S. for type 2 diabetes
Read More
BMT-4-159 is a new 17-beta-HSD 5 inhibitor with potential to treat prostate cancer
Read More
Orexo completes first clinical study of OX-27 for breakthrough cancer pain
Read More
Kareus Therapeutics and Quintiles enter strategic alliance
Read More
Data presented from two phase II trials of BCX-4208 with/without allopurinol in gout
Read More
AC-201 to enter phase IIb trial in type 2 diabetes
Read More
Servier holds option to acquire full Ampakine rights from Cortex Pharmaceuticals
Read More
Pronova BioPharma prepares to submit application for PRC-4016 trial in mixed dyslipidemia
Read More
New glycogen synthase activators presented
Read More
BiondVax reports phase IIa data on Multimeric-001 universal flu vaccine
Read More
Sanofi and Audion Therapeutics to develop treatments for hearing loss
Read More
MP4OX enters phase IIb trial in patients with trauma and lactic acidosis due to hemorrhagic shock
Read More
FDA accepts IntelGenx's resubmission of CPI-300 NDA
Read More
Istodax approved in U.S. as therapy for previously treated patients with peripheral T-cell lymphoma
Read More
Durasert-based latanoprost delivery implant enters phase I/II trial in patients with elevated IOP
Read More
FDA committee to review Seattle Genetic's Adcetris BLAs in July
Read More
Bardoxolone methyl enters pivotal trial in patients with chronic kidney disease and type 2 diabetes
Read More